AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
PHARMACISTS AND INFECTIOUS-DISEASES SPECIALISTS
Authors: BAUMAN JL MURPHY JE BERTINO JS
Citation: Jl. Bauman et al., PHARMACISTS AND INFECTIOUS-DISEASES SPECIALISTS, Clinical infectious diseases, 27(1), 1998, pp. 229-230
PREDICTION OF RESPONSE TO HEPATITIS-B VACCINE IN HEALTH-CARE WORKERS - WHOSE TITERS OF ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN SHOULD BE DETERMINED AFTER A 3-DOSE SERIES, AND WHAT ARE THE IMPLICATIONS IN TERMSOF COST-EFFECTIVENESS
Authors: ALIMONOS K NAFZIGER AN MURRAY J BERTINO JS
Citation: K. Alimonos et al., PREDICTION OF RESPONSE TO HEPATITIS-B VACCINE IN HEALTH-CARE WORKERS - WHOSE TITERS OF ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN SHOULD BE DETERMINED AFTER A 3-DOSE SERIES, AND WHAT ARE THE IMPLICATIONS IN TERMSOF COST-EFFECTIVENESS, Clinical infectious diseases, 26(3), 1998, pp. 566-571
QUANTIFICATION OF INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF MENSTRUAL-CYCLE PHASE ON CYP2D6 ACTIVITY AS MEASURED BY DEXTROMETHORPHANPHENOTYPING
Authors: KASHUBA ADM NAFZIGER AN KEARNS GL LEEDER JS SHIREY CS GOTSCHALL R GAEDIGK A BERTINO JS
Citation: Adm. Kashuba et al., QUANTIFICATION OF INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF MENSTRUAL-CYCLE PHASE ON CYP2D6 ACTIVITY AS MEASURED BY DEXTROMETHORPHANPHENOTYPING, Pharmacogenetics, 8(5), 1998, pp. 403-410
METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS OUTBREAK - A CONSENSUS PANELS DEFINITION AND MANAGEMENT GUIDELINES
Authors: WENZEL RP REAGAN DR BERTINO JS BARON EJ ARIAS K
Citation: Rp. Wenzel et al., METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS OUTBREAK - A CONSENSUS PANELS DEFINITION AND MANAGEMENT GUIDELINES, American journal of infection control, 26(2), 1998, pp. 102-110
DOSING OF AMINOGLYCOSIDES TO RAPIDLY ATTAIN PHARMACODYNAMIC GOALS ANDHASTEN THERAPEUTIC RESPONSE BY USING INDIVIDUALIZED PHARMACOKINETIC MONITORING OF PATIENTS WITH PNEUMONIA CAUSED BY GRAM-NEGATIVE ORGANISMS
Authors: KASHUBA ADM BERTINO JS NAFZIGER AN
Citation: Adm. Kashuba et al., DOSING OF AMINOGLYCOSIDES TO RAPIDLY ATTAIN PHARMACODYNAMIC GOALS ANDHASTEN THERAPEUTIC RESPONSE BY USING INDIVIDUALIZED PHARMACOKINETIC MONITORING OF PATIENTS WITH PNEUMONIA CAUSED BY GRAM-NEGATIVE ORGANISMS, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1842-1844
A DOSE-RESPONSE STUDY OF HEPATITIS-A VACCINE IN HEALTHY-ADULTS WHO ARE GREATER-THAN-OR-EQUAL-TO-30 YEARS OLD AND WEIGH GREATER-THAN-OR-EQUAL-TO-77 KG
Authors: BERTINO JS THOELEN S VANDAMME P BRYAN JP BECHERER PR FREY S HAYDEN FG MARCUS LC PARENTI DM SPERLING M CHAN ISF BROWN L NALIN D
Citation: Js. Bertino et al., A DOSE-RESPONSE STUDY OF HEPATITIS-A VACCINE IN HEALTHY-ADULTS WHO ARE GREATER-THAN-OR-EQUAL-TO-30 YEARS OLD AND WEIGH GREATER-THAN-OR-EQUAL-TO-77 KG, The Journal of infectious diseases, 178(4), 1998, pp. 1181-1184
EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A AS DETERMINED BY PHENOTYPING
Authors: KASHUBA ADM NAFZIGER AN KEARNS GL LEEDER JS GOTSCHALL R ROCCI ML KULAWY RW BECK DJ BERTINO JS
Citation: Adm. Kashuba et al., EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A AS DETERMINED BY PHENOTYPING, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 257-268
QUANTIFICATION OF 3-MONTH INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF SEX AND MENSTRUAL-CYCLE PHASE ON CYP3A ACTIVITY AS MEASURED BY PHENOTYPING WITH INTRAVENOUS MIDAZOLAM
Authors: KASHUBA ADM BERTINO JS ROCCI ML KULAWY RW BECK DJ NAFZIGER AN
Citation: Adm. Kashuba et al., QUANTIFICATION OF 3-MONTH INTRAINDIVIDUAL VARIABILITY AND THE INFLUENCE OF SEX AND MENSTRUAL-CYCLE PHASE ON CYP3A ACTIVITY AS MEASURED BY PHENOTYPING WITH INTRAVENOUS MIDAZOLAM, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 269-277
QUANTITATION OF 3-MONTH INTRAINDIVIDUAL VARIABILITY AND INFLUENCE OF SEX AND MENSTRUAL-CYCLE PHASE ON CYP1A2, N-ACETYLTRANSFERASE-2, AND XANTHINE-OXIDASE ACTIVITY DETERMINED WITH CAFFEINE PHENOTYPING
Authors: KASHUBA ADM BERTINO JS KEARNS GL LEEDER JS JAMES AW GOTSCHALL R NAFZIGER AN
Citation: Adm. Kashuba et al., QUANTITATION OF 3-MONTH INTRAINDIVIDUAL VARIABILITY AND INFLUENCE OF SEX AND MENSTRUAL-CYCLE PHASE ON CYP1A2, N-ACETYLTRANSFERASE-2, AND XANTHINE-OXIDASE ACTIVITY DETERMINED WITH CAFFEINE PHENOTYPING, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 540-551
THE INFLUENCE OF SEX AND MENSTRUAL-CYCLE (MC) ON CYP1A2, NAT2 AND XANTHINE-OXIDASE (XO) ACTIVITY
Authors: NAFZIGER AN KASHUBA ADM JAMES A KEARNS GL LEEDER JS GOTSCHALL R BERTINO JS
Citation: An. Nafziger et al., THE INFLUENCE OF SEX AND MENSTRUAL-CYCLE (MC) ON CYP1A2, NAT2 AND XANTHINE-OXIDASE (XO) ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 36-36
LONG-TERM INTRAINDIVIDUAL VARIABILITY (VAR) AND THE INFLUENCE OF SEX ON CYP2D6 ACTIVITY
Authors: BERTINO JS KASHUBA ADM SHIREY C KEARNS GL LEEDER JS GOTSCHALL R NAFZIGER AN
Citation: Js. Bertino et al., LONG-TERM INTRAINDIVIDUAL VARIABILITY (VAR) AND THE INFLUENCE OF SEX ON CYP2D6 ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 63-63
INFLUENCE OF SEX AND MENSTRUAL-CYCLE (MC) ON CYP3A ACTIVITY MEASURED BY PHENOTYPING WITH INTRAVENOUS MIDAZOLAM (MDZ)
Authors: KASHUBA ADM BERTINO JS ROCCI ML KULAWY RW BECK DJ NAFZIGER AN
Citation: Adm. Kashuba et al., INFLUENCE OF SEX AND MENSTRUAL-CYCLE (MC) ON CYP3A ACTIVITY MEASURED BY PHENOTYPING WITH INTRAVENOUS MIDAZOLAM (MDZ), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 65-65
EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A
Authors: KASHUBA ADM NAFZIGER AN KEARNS GL LEEDER JS GOTSCHALL R ROCCI ML KULAWY RW BECK DJ BERTINO JS
Citation: Adm. Kashuba et al., EFFECT OF FLUVOXAMINE THERAPY ON THE ACTIVITIES OF CYP1A2, CYP2D6, AND CYP3A, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 66-66
INTRANASAL MUPIROCIN FOR OUTBREAKS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
Authors: BERTINO JS
Citation: Js. Bertino, INTRANASAL MUPIROCIN FOR OUTBREAKS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, American journal of health-system pharmacy, 54(19), 1997, pp. 2185-2191
EDITORIAL RESPONSE - SINGLE DAILY DOSING OF AMINOGLYCOSIDES - A CONCEPT WHOSE TIME HAS NOT YET COME
Authors: BERTINO JS ROTSCHAFER JC
Citation: Js. Bertino et Jc. Rotschafer, EDITORIAL RESPONSE - SINGLE DAILY DOSING OF AMINOGLYCOSIDES - A CONCEPT WHOSE TIME HAS NOT YET COME, Clinical infectious diseases, 24(5), 1997, pp. 820-823
PHARMACOKINETICS OF GENTAMICIN AT TRADITIONAL VERSUS HIGH-DOSES - IMPLICATIONS FOR ONCE-DAILY AMINOGLYCOSIDE DOSING
Authors: DEMCZAR DJ NAFZIGER AN BERTINO JS
Citation: Dj. Demczar et al., PHARMACOKINETICS OF GENTAMICIN AT TRADITIONAL VERSUS HIGH-DOSES - IMPLICATIONS FOR ONCE-DAILY AMINOGLYCOSIDE DOSING, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1115-1119
EFFECTS OF MODERATE-DOSE VERSUS HIGH-DOSE TRIMETHOPRIM ON SERUM CREATININE AND CREATININE CLEARANCE AND ADVERSE REACTIONS
Authors: NADERER O NAFZIGER AN BERTINO JS
Citation: O. Naderer et al., EFFECTS OF MODERATE-DOSE VERSUS HIGH-DOSE TRIMETHOPRIM ON SERUM CREATININE AND CREATININE CLEARANCE AND ADVERSE REACTIONS, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2466-2470
IMMUNOGENICITY OF 2 DOSES OF YEAST RECOMBINANT HEPATITIS-B VACCINE INHEALTHY OLDER ADULTS
Authors: GELLIN BG GREENBERG RN HART RH BERTINO JS STEIN DH DELORIA MA CLEMENTSMANN ML
Citation: Bg. Gellin et al., IMMUNOGENICITY OF 2 DOSES OF YEAST RECOMBINANT HEPATITIS-B VACCINE INHEALTHY OLDER ADULTS, The Journal of infectious diseases, 175(6), 1997, pp. 1494-1497
A COMPARATIVE TRIAL OF STANDARD OR HIGH-DOSE S SUBUNIT RECOMBINANT HEPATITIS-B VACCINE VERSUS A VACCINE CONTAINING S SUBUNIT, PRE-S-1, AND PRE-S-2 PARTICLES FOR REVACCINATION OF HEALTHY ADULT NONRESPONDERS
Authors: BERTINO JS TIRRELL P GREENBERG RN KEYSERLING HL POLAND GA GUMP D KUMAR ML RAMSEY K
Citation: Js. Bertino et al., A COMPARATIVE TRIAL OF STANDARD OR HIGH-DOSE S SUBUNIT RECOMBINANT HEPATITIS-B VACCINE VERSUS A VACCINE CONTAINING S SUBUNIT, PRE-S-1, AND PRE-S-2 PARTICLES FOR REVACCINATION OF HEALTHY ADULT NONRESPONDERS, The Journal of infectious diseases, 175(3), 1997, pp. 678-681
EFFECT OF MENSTRUAL-CYCLE (MC) PHASE ON CYP2D6 ACTIVITY IN EXTENSIVE METABOLIZERS (EMS) AS MEASURED BY DEXTROMETHORPHAN PHENOTYPING (DM-P)
Authors: KASHUBA ADM SHIREY CS BERTINO JS KEARNS GL NAFZIGER AN
Citation: Adm. Kashuba et al., EFFECT OF MENSTRUAL-CYCLE (MC) PHASE ON CYP2D6 ACTIVITY IN EXTENSIVE METABOLIZERS (EMS) AS MEASURED BY DEXTROMETHORPHAN PHENOTYPING (DM-P), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 23-23
COMPARATIVE EFFECTS OF MODERATE DOSE (MD) AND HIGH-DOSE (HD) TRIMETHOPRIM (TMP) ON SERUM CREATININE (CR), CREATININE CLEARANCE (CRCL) AND ADVERSE EVENTS (AES)
Authors: NADERER O NAFZIGER AN BERTINO JS
Citation: O. Naderer et al., COMPARATIVE EFFECTS OF MODERATE DOSE (MD) AND HIGH-DOSE (HD) TRIMETHOPRIM (TMP) ON SERUM CREATININE (CR), CREATININE CLEARANCE (CRCL) AND ADVERSE EVENTS (AES), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 51-51
RAPID ACHIEVEMENT OF AMINOGLYCOSIDE (AG) PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) GOALS TO ATTAIN THERAPEUTIC RESPONSE (TR) IN GRAM-NEGATIVE PNEUMONIA (GNP) - USE OF LARGE LOADING DOSES (LD) WITH INDIVIDUALIZED PHARMACOKINETIC MONITORING (IPM)
Authors: KASHUBA ADM BERTINO JS NAFZIGER AN
Citation: Adm. Kashuba et al., RAPID ACHIEVEMENT OF AMINOGLYCOSIDE (AG) PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) GOALS TO ATTAIN THERAPEUTIC RESPONSE (TR) IN GRAM-NEGATIVE PNEUMONIA (GNP) - USE OF LARGE LOADING DOSES (LD) WITH INDIVIDUALIZED PHARMACOKINETIC MONITORING (IPM), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 54-54
DISTRIBUTION OF ORTHOPEDIC SURGEONS, LAWYERS, AND MALPRACTICE CLAIMS IN NEW-YORK
Authors: RIES MD BERTINO JS NAFZIGER AN
Citation: Md. Ries et al., DISTRIBUTION OF ORTHOPEDIC SURGEONS, LAWYERS, AND MALPRACTICE CLAIMS IN NEW-YORK, Clinical orthopaedics and related research, (337), 1997, pp. 256-260
PHARMACOKINETICS OF ORAL FLEROXACIN IN MALE AND PREMENOPAUSAL FEMALE VOLUNTEERS
Authors: BERTINO JS NAFZIGER AN
Citation: Js. Bertino et An. Nafziger, PHARMACOKINETICS OF ORAL FLEROXACIN IN MALE AND PREMENOPAUSAL FEMALE VOLUNTEERS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 789-791
INVESTIGATION OF BIOEQUIVALENCE AND TOLERABILITY OF INTRAMUSCULAR CEFTRIAXONE INJECTIONS BY USING 1-PERCENT LIDOCAINE, BUFFERED LIDOCAINE, AND STERILE WATER DILUENTS
Authors: HAYWARD CJ NAFZIGER AN KOHLHEPP SJ BERTINO JS
Citation: Cj. Hayward et al., INVESTIGATION OF BIOEQUIVALENCE AND TOLERABILITY OF INTRAMUSCULAR CEFTRIAXONE INJECTIONS BY USING 1-PERCENT LIDOCAINE, BUFFERED LIDOCAINE, AND STERILE WATER DILUENTS, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 485-487
Risultati: 1-25 | 26-38